home > pmps

Pharmaceutical Manufacturing and Packing Sourcer


Pharmaceutical Manufacturing and Packing Sourcer (PMPS) is a specialist journal designed to provide worldwide coverage of a range of topics relating to the pharmaceutical manufacturing and packaging sector.

Published quarterly, the journal functions as a platform of communication and information-sharing for executive and strategic decision-makers within the industry, identifying new trends and marketing opportunities as well as highlighting the latest innovations in this dynamic environment. PMPS is specifically designed to interest those in the pharmaceutical, biotech, nutritional and medical device industries who are actively seeking to source services for improved efficiency in what is an increasingly competitive market.


For further information please contact:

Garry Rubie

Angela Cottrell

We're also on Twitter! Follow us @PMPSmag  

Read our publications on the go in the Samedan app for iPhone and iPad. You can download issues for offline reading and our archives go as far back as 2008! Download for free on the App Store.

Click here to view the digital version of PMPS


Featured in this issue
The End of the Line
The End of the Line

Just A Phase

In recent years, the uptake of phase change materials for use in thermal packaging has been considerable. Richard Harrop believes that this is more than just a fly-by-night trend.
Event Review

High Standards

Speakers at PDA Europe’s recent Pharmaceutical Cold and Supply Chain Logistics Conference debated supply chain visibility, product integrity and industry best practices. Co-Chair Erik van Asselt reports.

Compressed Air

Pure and Simple

Sometimes referred to as the fourth utility, compressed air plays a vital part in manufacturing operations. But it is vulnerable to contamination, and this can come from many different sources. David Whelan at IMI Precision Engineering offers his thoughts on today’s purification technologies.

Edited by
Dr Graham Hughes
Consultant in
Published quarterly in
February, May,
August and October

Banner of Samedan app.PMPS on Samedan
Banner of RDD Europe on Samedan
Industry Events

Clinical Outsourcing and Partnering World Europe

10-11 March 2015, Business Design Centre, London

The 8th annual Clinical Outsourcing and Partnering World Europe examines strategies to drive forward clinical trials for the better in order to deliver the best outcome for patients.
More info >>

News and Press Releases

Mundipharma launches Remsima®▼ (infliximab), a new-generation value-based monoclonal antibody, in six European markets

Cambridge, UK, 25 February 2015 – Mundipharma International Limited’s network of independent associated companies are launching Remsima® (infliximab) this month in Germany, Italy, UK, Netherlands, Belgium and Luxembourg following expiry of the relevant patents and Supplementary Protection Certificates, having secured distribution rights from Celltrion Healthcare Hungary Kft for Remsima in these markets.
More info >>

air transport logo


White Papers

Pharmacovigilance and Risk Management Information in Centralised Applications in the EU

United BioSource Corporation (UBC)

Getting a new medication approved for the EU market through the centralised procedure can be complex and needs expertise. The new EU pharmacovigilance legislation (Good Vigilance Practice, GVP) is now in effect and applicants need to be fully compliant. It is critical to have a thorough understanding of the regulatory process and requirements, and the expectations with regards to the pharmacovigilance system and the risk management plan. Ensuring consistency and an appropriate level of detail in the documentation submitted as part of the approval process will help prevent unnecessary delays.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement